- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 407/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Patent holdings for IPC class C07D 407/14
Total number of patents in this class: 1089
10-year publication summary
|
81
|
69
|
71
|
60
|
107
|
114
|
69
|
76
|
62
|
25
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
30 |
| Merck Patent GmbH | 5909 |
30 |
| LG Chem, Ltd. | 17205 |
28 |
| Novartis AG | 11238 |
27 |
| Pfizer Inc. | 3322 |
20 |
| Rohm and Haas Electronic Materials Korea Ltd. | 546 |
18 |
| Janssen Pharmaceutica N.V. | 3839 |
16 |
| Astex Therapeutics Limited | 267 |
16 |
| Eisai R&D Management Co., Ltd. | 1304 |
15 |
| Boehringer Ingelheim International GmbH | 4629 |
14 |
| Samsung Display Co., Ltd. | 30585 |
12 |
| Idemitsu Kosan Co., Ltd. | 3995 |
12 |
| Takeda Pharmaceutical Company Limited | 2961 |
12 |
| Celgene Corporation | 1412 |
12 |
| F. Hoffmann-La Roche AG | 7958 |
11 |
| Bayer Cropscience AG | 2241 |
10 |
| Amgen Inc. | 3779 |
10 |
| Vertex Pharmaceuticals Incorporated | 1581 |
10 |
| Duk San Neolux Co., Ltd. | 512 |
9 |
| Nerviano Medical Sciences S.r.l. | 256 |
9 |
| Other owners | 768 |